MK-0000-131 AM2

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-131 AM2, covering 2012-11-22 to 2012-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)